Literature DB >> 6832821

Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement.

E Brummer, A M Sugar, D A Stevens.   

Abstract

With a new short-term assay, where the reduction of CFUs in the inoculum could be measured, we investigated the killing of the dimorphic fungal pathogen Blastomyces dermatitidis in its yeast phase by murine peritoneal macrophages. Peritoneal macrophages from concanavalin A- or Mycobacterium bovis BCG-treated mice, but not resident or thioglycolate-elicited macrophages, significantly reduced the CFUs of B. dermatitidis in the inoculum. The activation of peritoneal macrophages for fungicidal activity by concanavalin A treatment was shown to be dose dependent and transient, i.e., absent after 72 h. These results indicate that it is possible for murine peritoneal macrophages to kill B. dermatitidis in vitro. The addition of specific antibody or complement or both did not enhance the killing of B. dermatitidis by these nonspecifically activated macrophages.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832821      PMCID: PMC348022          DOI: 10.1128/iai.39.2.817-822.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  A microculture system for the measurement of antigen-induced murine lymphocyte proliferation: advantages of 5% horse serum and 5 X 10(-5) M mercaptoethanol.

Authors:  E Brummer; T W Vris; H S Lawrence
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

2.  Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Resistance against Cryptococcus conferred by intracellular bacteria and protozoa.

Authors:  L O Gentry; J S Remington
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

4.  Murine pulmonary alveolar macrophages: rates of bacterial ingestion, inactivation, and destruction.

Authors:  M Kim; E Goldstein; J P Lewis; W Lippert; D Warshauer
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

5.  Growth of Cryptococcus neoformans within human macrophages in vitro.

Authors:  R D Diamond; J E Bennett
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

6.  Experiments on lymphocyte-mediated cellular immunity in murine histoplasmosis.

Authors:  D H Howard; V Otto
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

7.  Pulmonary alveolar macrophage. Defender against bacterial infection of the lung.

Authors:  E Goldstein; W Lippert; D Warshauer
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

8.  Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs.

Authors:  G J Jakab; G M Green
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

9.  In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

Authors:  T G Mitchell; L Friedman
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

10.  Mechanisms of acquired resistance in mouse typhoid.

Authors:  R V Blanden; G B Mackaness; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  6 in total

1.  Fungicidal mechanisms of activated macrophages: evidence for nonoxidative mechanisms for killing of Blastomyces dermatitidis.

Authors:  E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  Correlation of susceptibility of immature mice to fungal infection (blastomycosis) and effector cell function.

Authors:  A Ganer; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 3.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

4.  Activation of murine polymorphonuclear neutrophils for fungicidal activity with supernatants from antigen-stimulated immune spleen cell cultures.

Authors:  E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

5.  Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans.

Authors:  F Nassar; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi.

Authors:  E Brummer; C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.